EXOSC6 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.145200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.889800E-01
Normal-vs-Stage2
7.233000E-01
Normal-vs-Stage3
3.859200E-01
Normal-vs-Stage4
9.107600E-01
Stage1-vs-Stage2
4.649800E-01
Stage1-vs-Stage3
2.280800E-01
Stage1-vs-Stage4
7.802800E-01
Stage2-vs-Stage3
2.397200E-01
Stage2-vs-Stage4
8.259200E-01
Stage3-vs-Stage4
4.251800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.242800E-01
Normal-vs-AfricanAmerican
9.250600E-01
Normal-vs-Asian
4.560600E-01
Caucasian-vs-AfricanAmerican
6.766600E-01
Caucasian-vs-Asian
3.623400E-01
AfricanAmerican-vs-Asian
2.332400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.403400E-01
Normal-vs-Female
7.590200E-01
Male-vs-Female
7.660600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.981400E-01
Normal-vs-Age(41-60Yrs)
8.525400E-01
Normal-vs-Age(61-80Yrs)
7.236400E-01
Normal-vs-Age(81-100Yrs)
6.818600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.537600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.238000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.162000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.004400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.070200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.429160E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.717400E-01
Normal-vs-Daily Drinker
6.100800E-01
Normal-vs-Weekly Drinker
7.982600E-01
Normal-vs-Occasional Drinker
9.572200E-01
Normal-vs-Social Drinker
9.234600E-01
Non Drinker-vs-Daily Drinker
4.997600E-01
Non Drinker-vs-Weekly Drinker
9.249000E-01
Non Drinker-vs-Occasional Drinker
6.675800E-01
Non Drinker-vs-Social Drinker
8.543600E-01
Daily Drinker-vs-Weekly Drinker
5.963800E-01
Daily Drinker-vs-Occasional Drinker
3.073000E-01
Daily Drinker-vs-Social Drinker
3.957200E-01
Weekly Drinker-vs-Occasional Drinker
6.307600E-01
Weekly Drinker-vs-Social Drinker
7.651400E-01
Occasional Drinker-vs-Social Drinker
8.061800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.486180E-01
Normal-vs-Grade 2
2.403600E-02
Normal-vs-Grade 3
4.878400E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.810200E-01
Grade 1-vs-Grade 3
4.825700E-02
Grade 1-vs-Grade 4
1.486180E-01
Grade 2-vs-Grade 3
4.844700E-04
Grade 2-vs-Grade 4
2.403600E-02
Grade 3-vs-Grade 4
4.878400E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.430000E-01
Normal-vs-NonDiabetic
8.292600E-01
Diabetic-vs-NonDiabetic
6.216800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.563200E-01
Normal-vs-NoPancreatitis
8.331600E-01
Pancreatitis-vs-NoPancreatitis
8.789800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.502800E-01
Normal-vs-N1
6.842800E-01
N0-vs-N1
3.890300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.510600E-01
Normal-vs-TP53-NonMutant
8.953200E-01
TP53-Mutant-vs-TP53-NonMutant
3.969200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
